| Literature DB >> 30143422 |
Christelle Doebelin1, Rémi Patouret1, Ruben D Garcia-Ordonez1, Mi Ra Chang1, Venkatasubramanian Dharmarajan1, Scott Novick1, Anthony Ciesla1, Sean Campbell2, Laura A Solt2, Patrick R Griffin1, Theodore M Kamenecka3.
Abstract
We sought to develop RORβ-selective probe molecules in order to investigate the function of the receptor in vitro and in vivo and its role in the pathophysiology of disease. To accomplish this, we modified a potent dual RORβ/RORγ inverse agonist from the primary literature with the goal of improving selectivity for RORβ vs RORγ. Truncation of the Western portion of the molecule ablated activity at RORγ and led to a potent series of RORβ modulators. Continued exploration of this series investigated alternate replacement cores for the aminothiazole ring. Numerous suitable replacements were found during the course of our SAR investigations and are reported herein.Entities:
Keywords: Aminothiophene; Nuclear receptor; RORβ; Selective ligand
Mesh:
Substances:
Year: 2018 PMID: 30143422 PMCID: PMC6238650 DOI: 10.1016/j.bmcl.2018.08.017
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823